SPS
UTHR icon

Susquehanna Portfolio Strategies’s United Therapeutics UTHR Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.63M Buy
6,701
+2,107
+46% +$1.19M 0.06% 344
2026
Q1 		$2.72M Hold
4,594
– – 0.04% 424
2025
Q4 		$2.24M Hold
4,594
– – 0.03% 473
2025
Q3 		$1.93M Buy
+4,594
New +$1.55M 0.03% 522
2024
Q1 		– Sell
-15,067
Closed -$3.31M – 962
2023
Q4 		$3.31M Buy
+15,067
New +$3.47M 0.06% 343

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Susquehanna Portfolio Strategies's UTHR Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its United Therapeutics (UTHR) stake by 46% in Q2 2026, buying an estimated $1.19M and bringing the position to 6,701 shares worth $3.63M. The position accounts for 0.06% of the portfolio, ranked #344.

Susquehanna Portfolio Strategies first reported a position in UTHR in Q4 2023 and has held it in 5 quarters since. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Susquehanna Portfolio Strategies held 6,701 shares of United Therapeutics worth $3.63M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 2,107 United Therapeutics shares in Q2 2026, an estimated $1.19M.
  • United Therapeutics made up 0.06% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #344 holding.
  • Susquehanna Portfolio Strategies first reported a position in United Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.